Roland Roller, Manuel Mayrdorfer, Wiebke Duettmann, Marcel G. Naik, Danilo Schmidt, Fabian Halleck, Patrik Hummel, Aljoscha Burchardt, Sebastian Möller, Peter Dabrock, Bilgin Osmanodja, Klemens Budde
{"title":"Evaluation of a clinical decision support system for detection of patients at risk after kidney transplantation","authors":"Roland Roller, Manuel Mayrdorfer, Wiebke Duettmann, Marcel G. Naik, Danilo Schmidt, Fabian Halleck, Patrik Hummel, Aljoscha Burchardt, Sebastian Möller, Peter Dabrock, Bilgin Osmanodja, Klemens Budde","doi":"10.1101/2022.05.12.22275019","DOIUrl":null,"url":null,"abstract":"Patient care after kidney transplantation requires integration of complex information to make informed decisions on risk constellations. Many machine learning models have been developed for detecting patient outcomes in the past years. However, performance metrics alone do not determine practical utility. Often, the actual performance of medical professionals on the given task is not known. We present a newly developed clinical decision support system (CDSS) for detection of patients at risk for rejection and death-censored graft failure. The CDSS is based on clinical routine data including 1516 kidney transplant recipients and more than 100 000 data points. Additionally, we conduct a reader study to compare the performance of the system to estimations of physicians at a nephrology department with and without the CDSS. Internal validation shows AUC-ROC scores of 0.83 for rejection, and 0.95 for graft failure. The reader study shows that although the predictions by physicians converge towards the suggestions made by the CDSS, performance in terms of AUC-ROC does not improve (0.6413 vs. 0.6314 for rejection; 0.8072 vs. 0.7778 for graft failure). Finally, the study shows that the CDSS detects partially different patients at risk compared to physicians without CDSS. This indicates that the combination of both, medical professionals and a CDSS might help detect more patients at risk for graft failure. However, the question of how to integrate such a system efficiently into clinical practice remains open.","PeriodicalId":501561,"journal":{"name":"medRxiv - Transplantation","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2022.05.12.22275019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Patient care after kidney transplantation requires integration of complex information to make informed decisions on risk constellations. Many machine learning models have been developed for detecting patient outcomes in the past years. However, performance metrics alone do not determine practical utility. Often, the actual performance of medical professionals on the given task is not known. We present a newly developed clinical decision support system (CDSS) for detection of patients at risk for rejection and death-censored graft failure. The CDSS is based on clinical routine data including 1516 kidney transplant recipients and more than 100 000 data points. Additionally, we conduct a reader study to compare the performance of the system to estimations of physicians at a nephrology department with and without the CDSS. Internal validation shows AUC-ROC scores of 0.83 for rejection, and 0.95 for graft failure. The reader study shows that although the predictions by physicians converge towards the suggestions made by the CDSS, performance in terms of AUC-ROC does not improve (0.6413 vs. 0.6314 for rejection; 0.8072 vs. 0.7778 for graft failure). Finally, the study shows that the CDSS detects partially different patients at risk compared to physicians without CDSS. This indicates that the combination of both, medical professionals and a CDSS might help detect more patients at risk for graft failure. However, the question of how to integrate such a system efficiently into clinical practice remains open.
肾移植后的患者护理需要整合复杂的信息,以便对风险星座做出明智的决定。在过去的几年里,已经开发了许多机器学习模型来检测患者的结果。然而,性能指标本身并不能决定实际效用。通常,医疗专业人员在给定任务中的实际表现是未知的。我们提出了一个新开发的临床决策支持系统(CDSS),用于检测有排斥和死亡审查移植失败风险的患者。CDSS基于临床常规数据,包括1516名肾移植受者和超过10万个数据点。此外,我们进行了一项读者研究,将该系统的性能与有CDSS和没有CDSS的肾脏病科医生的评估进行比较。内部验证显示,排斥反应的AUC-ROC评分为0.83,移植失败的AUC-ROC评分为0.95。读者研究表明,尽管医生的预测趋近于CDSS的建议,但AUC-ROC的表现并没有改善(0.6413比0.6314拒绝;0.8072 vs 0.7778移植失败)。最后,研究表明,与没有CDSS的医生相比,CDSS检测到部分不同的风险患者。这表明,医学专业人员和CDSS的结合可能有助于发现更多有移植失败风险的患者。然而,如何将这样一个系统有效地融入临床实践的问题仍然是开放的。